UnitedHealth Group (UNH) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

UNH Stock Forecast


UnitedHealth Group (UNH) stock forecast, based on 49 Wall Street analysts, predicts a 12-month average price target of $635.00, with a high of $635.00 and a low of $635.00. This represents a 8.54% increase from the last price of $585.04.

$450 $490 $530 $570 $610 $650 High: $635 Avg: $635 Low: $635 Last Closed Price: $585.04

UNH Stock Rating


UnitedHealth Group stock's rating consensus is Buy, based on 49 Wall Street analysts. The breakdown includes 1 Strong Buy (2.04%), 42 Buy (85.71%), 4 Hold (8.16%), 2 Sell (4.08%), and 0 Strong Sell (0.00%).

Buy
Total 49 2 4 42 1 Strong Sell Sell Hold Buy Strong Buy

UNH Price Target Upside V Benchmarks


TypeNameUpside
StockUnitedHealth Group8.54%
SectorHealthcare Stocks 33.91%
IndustryHealthcare Plans Stocks9.88%

Price Target Trends


1M3M12M
# Anlaysts--17
Avg Price Target--$608.71
Last Closing Price$585.04$585.04$585.04
Upside/Downside--4.05%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25721---28
Mar, 257201--28
Feb, 256201--27
Jan, 256203--29
Dec, 246194--29
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 09, 2024David WindleyJefferies$635.00$549.5315.55%8.54%
Oct 16, 2024Ben HendrixRBC Capital$595.00$556.296.96%1.70%
Oct 16, 2024David MacDonaldTruist Financial$625.00$556.2912.35%6.83%
Oct 16, 2024Joanna GajukBank of America Securities$650.00$556.2916.85%11.10%
Oct 16, 2024David WindleyJefferies$643.00$556.2915.59%9.91%
Oct 16, 2024George HillDeutsche Bank$595.00$556.296.96%1.70%
Oct 16, 2024Matthew GillmorKeyBanc$650.00$569.6614.10%11.10%
Oct 10, 2024Matthew GillmorKeyBanc$675.00$597.7012.93%15.38%
Jul 17, 2024David ToungArgus Research$600.00$565.786.05%2.56%
Jul 17, 2024David MacDonaldTruist Financial$640.00$548.8716.60%9.39%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Apr 15, 2025Morgan StanleyOverweightOverweighthold
Apr 15, 2025BernsteinOutperformOutperformhold
Mar 03, 2025StephensOverweightOverweighthold
Dec 09, 2024JefferiesBuyBuyhold
Dec 05, 2024StephensOverweightOverweighthold
Oct 22, 2024UBSBuyBuyhold
Oct 17, 2024HSBCBuyHolddowngrade
Oct 16, 2024Cantor FitzgeraldOverweightOverweighthold
Oct 16, 2024RBC CapitalOutperformOutperformhold
Oct 16, 2024StephensOverweightOverweighthold

Financial Forecast


EPS Forecast

$15 $23 $31 $39 $47 $55 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$16.28$18.33$21.54$24.12$15.51-----
Avg Forecast$16.74$18.84$22.02$24.96$27.61$29.72$33.50$38.08$43.85$50.63
High Forecast$17.04$19.18$22.77$25.02$27.79$30.08$34.27$39.69$44.83$51.76
Low Forecast$16.40$18.46$21.33$24.87$27.30$28.45$32.22$35.72$42.05$48.55
Surprise %-2.75%-2.71%-2.18%-3.37%-43.82%-----

Revenue Forecast

$250B $340B $430B $520B $610B $700B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$255.64B$285.27B$322.13B$367.53B$400.28B-----
Avg Forecast$256.44B$286.74B$323.88B$369.14B$400.99B$450.84B$486.57B$522.61B$589.76B$675.82B
High Forecast$260.00B$290.73B$332.33B$370.46B$402.87B$453.61B$497.97B$523.71B$599.90B$687.44B
Low Forecast$252.46B$282.29B$316.03B$367.79B$400.03B$441.53B$469.85B$521.51B$571.09B$654.43B
Surprise %-0.31%-0.51%-0.54%-0.44%-0.18%-----

Net Income Forecast

$5B $14B $23B $32B $41B $50B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$15.40B$17.29B$20.12B$22.38B$14.40B-----
Avg Forecast$12.47B$15.70B$17.98B$22.38B$25.59B$27.19B$30.89B$35.03B$40.74B$47.04B
High Forecast$14.97B$18.84B$21.58B$26.86B$25.81B$27.95B$31.83B$36.87B$41.65B$48.09B
Low Forecast$9.98B$12.56B$14.39B$17.90B$25.36B$26.43B$29.94B$33.18B$39.06B$45.10B
Surprise %23.48%10.10%11.89%--43.70%-----

UNH Forecast FAQ


Is UnitedHealth Group stock a buy?

UnitedHealth Group stock has a consensus rating of Buy, based on 49 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 42 Buy, 4 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that UnitedHealth Group is a favorable investment for most analysts.

What is UnitedHealth Group's price target?

UnitedHealth Group's price target, set by 49 Wall Street analysts, averages $635 over the next 12 months. The price target range spans from $635 at the low end to $635 at the high end, suggesting a potential 8.54% change from the previous closing price of $585.04.

How does UnitedHealth Group stock forecast compare to its benchmarks?

UnitedHealth Group's stock forecast shows a 8.54% upside, underperforming the average forecast for the healthcare stocks sector (33.91%) and underperforming the healthcare plans stocks industry (9.88%).

What is the breakdown of analyst ratings for UnitedHealth Group over the past three months?

  • April 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 25.00% Strong Buy, 71.43% Buy, 3.57% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 22.22% Strong Buy, 74.07% Buy, 3.70% Hold, 0% Sell, 0% Strong Sell.

What is UnitedHealth Group’s EPS forecast?

UnitedHealth Group's average annual EPS forecast for its fiscal year ending in December 2025 is $29.72, marking a 91.62% increase from the reported $15.51 in 2024. Estimates for the following years are $33.5 in 2026, $38.08 in 2027, $43.85 in 2028, and $50.63 in 2029.

What is UnitedHealth Group’s revenue forecast?

UnitedHealth Group's average annual revenue forecast for its fiscal year ending in December 2025 is $450.84B, reflecting a 12.63% increase from the reported $400.28B in 2024. The forecast for 2026 is $486.57B, followed by $522.61B for 2027, $589.76B for 2028, and $675.82B for 2029.

What is UnitedHealth Group’s net income forecast?

UnitedHealth Group's net income forecast for the fiscal year ending in December 2025 stands at $27.19B, representing an 88.73% increase from the reported $14.4B in 2024. Projections indicate $30.89B in 2026, $35.03B in 2027, $40.74B in 2028, and $47.04B in 2029.